MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    LFP spectral features associated with therapy complications in typical and early onset Parkinson’s disease

    E. Belova, U. Semenova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: The aim of this study was to search for potential markers in the subthalamic nucleus activity of parkinsonian patients associated with levodopa-induced dyskinesias in…
  • MDS Virtual Congress 2021

    Evoked potentials as biomarker for deep brain stimulation programming in Parkinson’s disease

    J. Peeters, A. Boogers, T. van Bogaert, R. Gransier, J. Wouters, B. Nuttin, M. Mc Laughlin (Leuven, Belgium)

    Objective: To correlate evoked potentials (EPs) during electrical stimulation of subthalamic nucleus, to clinical outcome measures in Parkinson’s disease (PD) patients, to guide deep brain…
  • MDS Virtual Congress 2021

    Links between Cognitive Impairment and Contrast Sensitivity in Parkinson’s Disease

    C. Catiul, R. Memon, A. Memon, A. Joop, J. Pilkington, K. Wood, A. Amara (Birmingham, USA)

    Objective: To evaluate the relationship between Contrast Sensitivity (CS) and cognitive function in patients with idiopathic Parkinson’s Disease (PD) and healthy controls (HC). Background: In…
  • MDS Virtual Congress 2021

    The prevalence of sarcopenia in Parkinson’s disease and related disorders

    A. Hart, F. Barker, A. Sayer, A. Granic, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To systematically review the prevalence of sarcopenia in Parkinson’s disease (PD) and atypical parkinsonian syndromes (aPS), how prevalence differs with PD stage and between…
  • MDS Virtual Congress 2021

    CLINICAL CHARACTERISTICS OF PARKINSON’S DISEASE WITH PROBABLE RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER

    S. Marisdina, A. Afriani, M. Mukhlisa, S. Handayani, O. Tambun, R. Nindela, Y. Diansari (Palembang, Indonesia)

    Objective: To determine the clinical characteristics of Parkinson’s Disease (PD) patients with probable Rapid eye movement sleep behavior disorder (pRBD) compared to PD patients without…
  • MDS Virtual Congress 2021

    Impact of COVID-19 pandemic on development of chronic stress syndromes in patients with Parkinson’s Disease : preliminary results

    C. Pauly, M. Hansen, L. Delacour, C. Martin-Gallausiaux, P. Wilmes, R. Krüger, N. Diederich (Esch-Sur-Alzette, Luxembourg)

    Objective: To evaluate the impact of COVID-19 pandemic on patients with Parkinson’s disease (PD), namely their risk for development of chronic stress syndromes. Background: It…
  • MDS Virtual Congress 2021

    THE ASSOCIATION OF ANXIETY AND DEPRESSION WITH TREMORS IN PARKINSON’S DISEASE PATIENTS

    F. Susanti, C. Arina, H. Hutagalung (Medan, Indonesia)

    Objective: To determine the relation between anxiety and depression with tremors in patients with PD so that it can be possible to detect the symptoms…
  • MDS Virtual Congress 2021

    Using smartphone data to infer social behaviour in Parkinson’s: proof of principle and the impact of COVID19

    H. Zhang, E. Poliakoff, B. Parsia, S. Harper (Manchester, United Kingdom)

    Objective: To investigate the potential of using smartphone data to infer changes in social behaviour in people with Parkinson's and how this has been impacted…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley